For years, every company chasing the dream of commercial fusion energy has faced the same irritating reality: before you can prove your reactor works, you need sophisticated instruments to measure what's happening inside a roiling ball of superheated plasma. And almost everyone builds those instruments themselves, burning through capital and engineering hours to reinvent variations of the same diagnostic tools.
W. Henry Gould spent enough time building those systems at General Fusion to recognize the inefficiency. Now he's betting that fusion companies would rather buy than build.
His Toronto-based venture, Daedal Systems, disclosed in late September that it had raised $4.035 million in an oversubscribed pre-seed round led by OMERS Ventures. Garage Capital, Panache Ventures, Ripple Ventures, the MaRS Investment Accelerator Fund and a cluster of angel investors joined the financing, which actually closed in July.
The pitch is straightforward, if ambitious: Daedal will design, build and operate standardized plasma measurement systems for fusion developers under full-service contracts. Instead of each company engineering its own Thomson scattering diagnostic or X-ray crystal spectroscopy rig, they rent Daedal's equipment and get third-party validated data in return.
"After building and deploying plasma measurement systems at General Fusion, I saw the same challenge across the sector," Gould said in announcing the funding. "Every company needs high-quality diagnostics, but too much time and capital go into recreating similar systems in-house."
It's a supplier play in an industry that has lately attracted the kind of capital once reserved for rocket startups and artificial intelligence labs. Private fusion ventures pulled in $4.48 billion in the twelve months through mid-2026, pushing cumulative investment to $14.24 billion spread across 56 companies, according to the Fusion Industry Association. Supplier spending was up 24% in 2025, the trade group reported.
Daedal's immediate plans involve building its first three diagnostic systems and deploying prototypes with pilot customers.
Standardizing the Unstandardizable
The technical challenge Daedal faces is not trivial. Fusion reactors come in wildly different architectures—tokamaks, stellarators, inertial confinement schemes, alternative magnetic confinement designs. Each presents unique measurement problems.
Daedal's initial focus centers on Thomson scattering and X-ray crystal spectroscopy for magnetic confinement machines, the designs that confine plasma using powerful magnetic fields. The company's roadmap, at least according to its website, extends to electron cyclotron emission diagnostics, reflectometry, polarimetry, magnetic diagnostics, Langmuir probes, and systems for detecting neutrons and gamma radiation.
Whether a single vendor can truly standardize diagnostics across such varied reactor types remains an open question. Gould's experience offers some credibility. As technical project manager for plasma diagnostics at General Fusion, he oversaw reflectometry systems and other measurement projects. Alon Hazan, who joined Daedal as chief technology and product officer, previously spent six years as CTO at RetiSpec, a medical diagnostics company.
The startup has assembled a roster of advisors with serious pedigree in plasma physics, including Dr. Johan Frenje, a senior research scientist at MIT's Plasma Science and Fusion Center, along with John Rice and Earl Scime.
Early Interest, But No Revenue Yet
Daedal has inked eight memoranda of understanding since its launch, according to Panache Ventures. MOUs, of course, are preliminary agreements—expressions of interest rather than binding contracts. Still, the roster includes some recognizable names in the fusion world.
Proxima Fusion is exploring Daedal as the prime contractor for diagnostic systems on its Alpha stellarator. OpenStar Technologies, Stellarex Energy Group and Marathon Fusion have also signed on as partners, based on LinkedIn posts from the company.
The underlying bet is that as fusion ventures mature, they'll face mounting pressure to focus capital and talent on their core reactor technology rather than ancillary systems. A February report from a Department of Energy Basic Research Needs Workshop reinforced that logic, calling for increased investment in fusion diagnostic capabilities and faster progress in measurement technologies.
"Advanced plasma diagnostics were among the key enabling technologies that led to ignition and target gain at the NIF," Frenje noted, referencing the National Ignition Facility's landmark achievement in December 2022, when researchers briefly produced more energy from fusion than the lasers pumped into the target.
Brian Kobus, managing partner at OMERS Ventures, framed Daedal's role in ecosystem terms. The company, he suggested, could help "strengthen that ecosystem and attract the expertise required to advance this important technology."
Whether fusion companies will actually outsource something as mission-critical as plasma diagnostics—or whether they'll cling to the control that comes with in-house development—will determine if Daedal's model works. For now, Gould is placing his chips on standardization in an industry that has historically resisted it.
